Equities

SQI Diagnostics Inc

SQD.H:NEX

SQI Diagnostics Inc

Actions
  • Price (CAD)0.015
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change-75.00%
  • Beta-0.4024
Data delayed at least 15 minutes, as of Sep 07 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

  • Revenue in CAD (TTM)3.04m
  • Net income in CAD-19.13m
  • Incorporated2003
  • Employees55.00
  • Location
    SQI Diagnostics Inc36 Meteor DrETOBICOKE M9W 1A4CanadaCAN
  • Phone+1 (416) 674-9500
  • Fax+1 (416) 674-9500
  • Websitehttps://sqidiagnostics.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lattice Biologics Ltd2.12m-1.30m4.14m--------1.95-0.0102-0.01020.01670.00111.013.838.70---61.69------28.53---61.08--0.00-1.020.00--12.60---46.52------
SQI Diagnostics Inc3.04m-19.13m6.10m55.00------2.01-0.0483-0.04830.0077-0.0350.2863.233.91---179.74-147.99---264.3310.9748.25-628.52-400.280.1193-3.0324.07--783.5352.95-75.46--42.57--
Evome Medical Technologies Inc62.63m-15.60m10.11m195.00--3.69--0.1615-0.2094-0.20940.80690.04741.254.378.85321,166.50-31.11---95.79--35.98---24.91--0.2864-2.090.8605--------------
Hapbee Technologies Inc1.30m-3.69m10.92m--------8.43-0.052-0.0520.0165-0.0270.37272.657.52---106.18---1,124.43--41.98---284.93--0.1167-------47.73--26.20------
Cloud DX Inc1.81m-10.35m11.21m--------6.19-0.1109-0.11090.0204-0.19120.83342.829.32---475.88------76.97---570.98--0.049-2.32----55.39--2.56------
Aurora Spine Corp21.20m-1.75m19.80m13.00--3.14--0.9342-0.0243-0.02430.29140.08911.421.924.09---11.69-16.00-16.45-22.2358.8646.65-8.25-11.761.39-5.800.4195---2.4010.83-11.93--10.36--
NuGen Medical Devices Inc331.41k-9.36m21.33m--------64.36-0.0572-0.05720.002-0.0104----------------49.74---2,824.97--0.3405-5.961.35--117.51---67.84------
Medx Health Corp456.09k-4.58m22.25m--------48.79-0.0242-0.02420.0023-0.02730.64790.758257.37---650.72-653.82----40.7049.55-1,004.31-736.740.0384-1.40-----10.68-15.9510.77------
Enablence Technologies Inc2.11m-14.75m22.39m202.00------10.61-0.7933-0.79330.1135-1.290.69857.639.45---488.37-191.45-----119.94-61.64-699.16-250.290.2346-3.46-----0.8595-10.36-173.59--5.99--
Data as of Sep 07 2023. Currency figures normalised to SQI Diagnostics Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.